Clinical trial
Evaluation of Chemotherapy as Initial Treatment for Retinoblastoma
NCT00002794 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Chemotherapy as Initial Treatment for Retinoblastoma
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 1996
- Completion date
- June 30, 2001
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.